SoftBank Group

SoftBank Group is a multinational telecommunications and internet corporation based in Japan. It operates through four segments: mobile communications, Sprint, fixed-line telecommunications, and internet. The company provides a wide range of services, including mobile and fixed-line voice and data transmission services, broadband services, internet advertising, e-commerce, and digital television. SoftBank Group also invests in various technologies through its venture capital arms, such as SoftBank Investment Advisers and SoftBank Vision Fund, focusing on areas like artificial intelligence, robotics, and the Internet of Things. One of its notable subsidiaries, SoftBank Robotics, designs and manufactures humanoid robots for various applications, including education, healthcare, and business.

Karim Abouzahr

Director, SoftBank Europe Ventures

Praveen Akkiraju

Managing Partner, Americas, Asia

Kristin Bannon

Investment Director, SoftBank Investment Advisers

Lee Bocker

COO

Jonathan Bullock

COO and Managing Director

John Cassidy

Investment Director, Life Sciences and HealthTech

Tom Cheung

Partner, Americas

Rodrigo Costa

Partner

Serena Dayal

Investment Director

Angela Du

Investor

Colin Fan

Managing Partner, SoftBank Investment Advisers

Ted Fike

Director, Americas

Ronald Fisher

Vice Chairman

Navneet Govil

Managing Partner, CFO

Ayush Jain

Investment Vice President

Lydia Jett

Partner

Sumer Juneja

Managing Partner and Head of EMEA and India Investing

Robert Kaplan

Investment Director

Nagraj Kashyap

Managing Partner

Matt Krna

Principal

Chris Lee

Partner, Asia

Anna Lo

Director, Americas

Amit Lubovsky

Investor

Jimi Macdonald

Director

Kentaro Matsui

Managing Partner, Asia

Ken Miyauchi

Representative Director and Senior Executive Vice President

Greg Moon

Associate

Akshay Naheta

Partner, EMEA

Gowri Narayanan

Partner, FinTech

Karol Niewiadomski

Partner

Shu Nyatta

Managing Partner

Max Ohrstrand

Partner, EMEA

Vikas Parekh

Managing Partner, Americas

Ben Parton

Director of Deals and Transactions

Paulo Passoni

Managing Investment Partner

Yanni Pipilis

Managing Partner

Narendra Rathi

Director, Asia

Brett Rochkind

Managing Partner

Saleh Romeih

Managing Partner, Investment Committee Member, SBIA, EMEA

Ram Trichur

Partner

Ervin Tu

Partner, Americas

Munish Varma

Partner, EMEA, Asia

Aaron Wong

Vice President

Kenichi Yoshida

Chief Business Officer and Executive Vice President

Linda Yu

Vice President, Vision Fund

Andrew Zloto

Investment Director

Tim Yap

Director, EMEA

Past deals in Massachussets

Cybereason

Series H in 2025
Cybereason Inc. is a cybersecurity company that specializes in endpoint protection, offering a comprehensive platform for endpoint detection and response, next-generation antivirus, and anti-ransomware solutions. Founded in 2012 and headquartered in Boston, Massachusetts, with additional offices in London, Tel Aviv, and Tokyo, Cybereason's platform is distinguished by its custom-built in-memory graph, an automated hunting engine that identifies behavioral patterns across endpoints and reveals malicious operations. The platform includes various products designed to detect, analyze, and respond to cyber threats in real time, such as Deep Detect & Respond, Deep Prevent, Deep Investigate, and Deep Respond. Among its offerings is RansomFree, which protects against ransomware attacks. The company also provides managed monitoring services, surveillance, investigation, and training to bolster enterprise security against advanced cyber adversaries.

ElevateBio

Series D in 2023
ElevateBio, LLC is a holding company based in Cambridge, Massachusetts, founded in 2017. It focuses on developing cell and gene therapies for the treatment of cancer and viral infections. The company operates a portfolio of subsidiaries that aim to manufacture and commercialize innovative medicines. ElevateBio collaborates with leading scientists and inventors to create a robust portfolio of therapeutic solutions. Additionally, it has established a centralized facility designed to streamline the translation of cell and gene therapy research into viable medical products, ensuring that patients have access to treatments for severe diseases in a timely manner.

Cybereason

Venture Round in 2023
Cybereason Inc. is a cybersecurity company that specializes in endpoint protection, offering a comprehensive platform for endpoint detection and response, next-generation antivirus, and anti-ransomware solutions. Founded in 2012 and headquartered in Boston, Massachusetts, with additional offices in London, Tel Aviv, and Tokyo, Cybereason's platform is distinguished by its custom-built in-memory graph, an automated hunting engine that identifies behavioral patterns across endpoints and reveals malicious operations. The platform includes various products designed to detect, analyze, and respond to cyber threats in real time, such as Deep Detect & Respond, Deep Prevent, Deep Investigate, and Deep Respond. Among its offerings is RansomFree, which protects against ransomware attacks. The company also provides managed monitoring services, surveillance, investigation, and training to bolster enterprise security against advanced cyber adversaries.

Vendr

Series B in 2022
Vendr, Inc. is a Boston-based company that specializes in a software-as-a-service (SaaS) platform designed to streamline the purchasing and renewal processes of software for businesses. Founded in 2018, Vendr offers a comprehensive suite of services including commercial negotiations, renewal management, and contract logistics. The platform empowers finance and procurement teams by providing access to extensive data from numerous transactions, enabling them to find suitable software, negotiate favorable prices, and manage renewals effortlessly. Vendr's commitment to simplifying SaaS procurement has positioned it as a leader in the industry, further enhanced by its recent acquisition of the SaaS management platform, Blissfully.

Proximie

Series C in 2022
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.

Cornami

Series C in 2022
Cornami, Inc. is a high-performance computing company based in Campbell, California, with additional offices in Sacramento and Boston. Founded in 2011, Cornami has developed a patented multi-core technology that enhances software performance, power efficiency, and latency while significantly increasing compute performance. This innovative approach allows processor cores to function as scalable resources, similar to memory and storage, facilitating real-time computing with minimal cost and power consumption. Cornami's technology aims to support a variety of markets, with an initial emphasis on Big Data, by enabling real-time fully homomorphic encryption and providing high-performance computing capabilities across diverse devices and platforms.

RightHand Robotics

Series C in 2022
RightHand Robotics, Inc. specializes in the manufacturing of robotic order-picking systems designed to enhance supply chain logistics and order fulfillment across various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015, the company is headquartered in Cambridge, Massachusetts, with an additional office in Frankfurt, Germany. RightHand Robotics offers innovative solutions like the ReFlex SF, which features a 3D-printed palm equipped with advanced servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that aids in gentle object handling. Their technology enables robots to automatically grasp a wide range of items from bins and cases without the need for extensive data entry or parameter tuning, making their systems cost-effective and adaptable to changing business needs.

Dewpoint Therapeutics

Series C in 2022
Dewpoint Therapeutics is a Boston-based biotech company focused on the research and development of treatments targeting biomolecular condensates to address various diseases, including cancer, neurodegenerative disorders, and immunological conditions. Founded in 2018, the company employs an innovative drug platform that utilizes machine-learning-based image analysis for visualizing condensates. This technology supports an engine of engineered cell lines designed to track and mitigate harmful protein sequestration. By leveraging its proprietary platform, Dewpoint seeks to facilitate drug discovery across a wide range of medical indications and collaborates with leading academic and pharmaceutical partners to enhance the accessibility of new therapies for unmet healthcare needs.

ezCater

Series D in 2021
ezCater, Inc. is an online catering marketplace that facilitates food ordering for both small startups and large corporations. Founded in 2007 and headquartered in Boston, Massachusetts, with an additional office in Denver, the company connects businesses with local caterers and restaurants across the nation. ezCater offers a platform that allows users to easily find and order food for meetings and events, utilizing features that filter caterers by food type, budget, and other criteria. The company's solutions include ezManage, a catering management platform, and ezOrdering, which enables restaurants to accept catering orders directly through their websites. By streamlining the catering process, ezCater helps clients save time and efficiently select suitable catering options.

Pear Therapeutics

Post in 2021
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

Cornami

Series C in 2021
Cornami, Inc. is a high-performance computing company based in Campbell, California, with additional offices in Sacramento and Boston. Founded in 2011, Cornami has developed a patented multi-core technology that enhances software performance, power efficiency, and latency while significantly increasing compute performance. This innovative approach allows processor cores to function as scalable resources, similar to memory and storage, facilitating real-time computing with minimal cost and power consumption. Cornami's technology aims to support a variety of markets, with an initial emphasis on Big Data, by enabling real-time fully homomorphic encryption and providing high-performance computing capabilities across diverse devices and platforms.

Whoop

Series F in 2021
Whoop, Inc. is a Boston-based company that specializes in the development and sale of wearable fitness sensors designed for athletes to monitor their physiological metrics during workouts. Founded in 2012, Whoop provides a performance optimization system that continuously tracks key indicators such as heart rate, sleep, and recovery. The company's flagship product, the Whoop Strap 3.0, collects data around the clock, offering users insights that help balance training, minimize injuries, and enhance overall performance. In addition to the wearable device, Whoop offers a variety of apparel and accessories, including bands, tops, joggers, and hats, primarily sold online. By delivering personalized insights into physical exertion and recovery, Whoop aims to help athletes and teams maximize their potential and improve their training outcomes.

Gelato

Venture Round in 2021
Gelato operates an on-demand printing platform that specializes in customized print products. It enables entrepreneurs, creators, and global brands to sell their products worldwide while producing them locally in 30 countries, thus streamlining the logistics and eliminating the need for inventory management or cross-border shipping. This approach allows businesses of all sizes to efficiently scale their e-commerce operations, reaching a vast consumer base of up to 5 billion people. Gelato's commitment to sustainability and efficiency positions it as a leader in the customized print market. The company has a global presence with offices in key cities, including Boston, London, and Tokyo, while headquartered in Oslo, Norway.

Cybereason

Series F in 2021
Cybereason Inc. is a cybersecurity company that specializes in endpoint protection, offering a comprehensive platform for endpoint detection and response, next-generation antivirus, and anti-ransomware solutions. Founded in 2012 and headquartered in Boston, Massachusetts, with additional offices in London, Tel Aviv, and Tokyo, Cybereason's platform is distinguished by its custom-built in-memory graph, an automated hunting engine that identifies behavioral patterns across endpoints and reveals malicious operations. The platform includes various products designed to detect, analyze, and respond to cyber threats in real time, such as Deep Detect & Respond, Deep Prevent, Deep Investigate, and Deep Respond. Among its offerings is RansomFree, which protects against ransomware attacks. The company also provides managed monitoring services, surveillance, investigation, and training to bolster enterprise security against advanced cyber adversaries.

Perch

Series A in 2021
Perch is a technology-driven commerce company based in Boston, Massachusetts, that specializes in acquiring and operating successful Amazon FBA (Fulfillment by Amazon) businesses. The company focuses on products with a proven track record of strong customer reviews and consistently ranks among the top three in their respective categories on Amazon. Its portfolio includes a diverse range of brands, such as those producing exfoliating brushes, slime-making kits, leggings, and reusable straws. Perch utilizes its platform for sales analytics, pricing, advertising, marketing strategies, and inventory management to optimize the performance of its acquired businesses. Founded in 2019, Perch leverages data and technology to enhance its operations and drive growth in the e-commerce space.

Formlabs

Series E in 2021
Formlabs Inc. is a company that designs and manufactures advanced 3D printing systems targeted at engineers, designers, and artists. Established in 2011 and headquartered in Somerville, Massachusetts, Formlabs offers a diverse range of products, including the Form 3, Form 3B, and Form 3L printers, all utilizing Low Force Stereolithography (LFS) technology. The company also provides post-processing solutions such as Form Wash and Form Cure, as well as the Fuse 1 SLS 3D printer and the Form Cell manufacturing solution. Formlabs develops high-performance materials for various applications in industries like dental, healthcare, jewelry, and education. Its PreForm software facilitates the preparation of models for printing, making it a preferred choice among professionals worldwide. With additional offices in Germany, Japan, China, Singapore, Hungary, and North Carolina, Formlabs continues to innovate in the field of 3D printing, enhancing the capabilities of digital fabrication.

Repertoire Immune Medicines

Series B in 2021
Repertoire Immune Medicines is a clinical-stage biotechnology company founded in 2016 and based in Cambridge, Massachusetts. The company focuses on harnessing the power of T cells to develop innovative therapies aimed at preventing, treating, and curing cancer, autoimmune conditions, and infectious diseases. Repertoire Immune Medicines is actively engaged in experimental clinical trials that utilize autologous T cells primed against specific cancer antigens and linked to IL-15. Additionally, the company specializes in the characterization of T cell receptor (TCR)-antigen pairs, allowing for the rational design and development of targeted immune medicines. These efforts are designed to enhance the human immune system's capabilities, providing new treatment options for patients with serious health challenges.

ElevateBio

Series C in 2021
ElevateBio, LLC is a holding company based in Cambridge, Massachusetts, founded in 2017. It focuses on developing cell and gene therapies for the treatment of cancer and viral infections. The company operates a portfolio of subsidiaries that aim to manufacture and commercialize innovative medicines. ElevateBio collaborates with leading scientists and inventors to create a robust portfolio of therapeutic solutions. Additionally, it has established a centralized facility designed to streamline the translation of cell and gene therapy research into viable medical products, ensuring that patients have access to treatments for severe diseases in a timely manner.

Pear Therapeutics

Series D in 2020
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

Whoop

Series E in 2020
Whoop, Inc. is a Boston-based company that specializes in the development and sale of wearable fitness sensors designed for athletes to monitor their physiological metrics during workouts. Founded in 2012, Whoop provides a performance optimization system that continuously tracks key indicators such as heart rate, sleep, and recovery. The company's flagship product, the Whoop Strap 3.0, collects data around the clock, offering users insights that help balance training, minimize injuries, and enhance overall performance. In addition to the wearable device, Whoop offers a variety of apparel and accessories, including bands, tops, joggers, and hats, primarily sold online. By delivering personalized insights into physical exertion and recovery, Whoop aims to help athletes and teams maximize their potential and improve their training outcomes.

XtalPi Technology

Series C in 2020
XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.

Zymergen

Series D in 2020
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. Founded in 2013 and headquartered in Emeryville, California, Zymergen employs a platform that integrates automation, machine learning, and genomics to enhance the efficiency of microbial strain optimization and production processes. This technology enables the company to improve existing manufacturing strains and facilitates the development of new products by engineering novel molecules from microbes. With additional offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, Zymergen aims to partner with nature to create innovative materials and products that deliver significant value across multiple sectors.

Biofourmis

Series C in 2020
Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.

Automation Anywhere

Series B in 2019
Automation Anywhere, Inc. is a global leader in Robotic Process Automation (RPA), specializing in the development of AI-powered software solutions designed to enhance business efficiency. Founded in 2003 and headquartered in San Jose, California, the company offers a cloud-native platform that integrates RPA with artificial intelligence, machine learning, and analytics. Its flagship products include Automation Anywhere Enterprise, which automates IT and business processes; Automation Anywhere Server for streamlined business operations; and IQ Bot, a cognitive automation solution that addresses complex business tasks. Additionally, the company provides a comprehensive suite of testing tools, such as Testing Anywhere, which supports quality assurance across various platforms. Automation Anywhere also offers consulting services and collaborates strategically with Microsoft Azure. The company has expanded its presence internationally with offices in several major cities across the United States, Europe, the Middle East, and Asia.

Cybereason

Series E in 2019
Cybereason Inc. is a cybersecurity company that specializes in endpoint protection, offering a comprehensive platform for endpoint detection and response, next-generation antivirus, and anti-ransomware solutions. Founded in 2012 and headquartered in Boston, Massachusetts, with additional offices in London, Tel Aviv, and Tokyo, Cybereason's platform is distinguished by its custom-built in-memory graph, an automated hunting engine that identifies behavioral patterns across endpoints and reveals malicious operations. The platform includes various products designed to detect, analyze, and respond to cyber threats in real time, such as Deep Detect & Respond, Deep Prevent, Deep Investigate, and Deep Respond. Among its offerings is RansomFree, which protects against ransomware attacks. The company also provides managed monitoring services, surveillance, investigation, and training to bolster enterprise security against advanced cyber adversaries.

Boston Dynamics

Venture Round in 2019
Boston Dynamics, Inc. is an engineering company based in Waltham, Massachusetts, specializing in the design and manufacture of advanced robots and software for human simulation. Founded in 1992 as a spin-off from the Massachusetts Institute of Technology, the company has gained recognition for its innovative robots that mimic animal movement, such as Spot, a quadruped robot, and Atlas, a humanoid robot. These robots are equipped with cutting-edge mobility, dexterity, and intelligence, allowing them to perform tasks in challenging environments, including industrial plants, construction sites, and warehouses. Boston Dynamics also develops software for human simulation, which is utilized in various training applications, including law enforcement and military operations. The company collaborates with organizations globally, providing solutions to some of the most complex challenges in automation and robotics.

Relay Therapeutics

Series C in 2018
Relay Therapeutics, Inc. is a clinical-stage precision medicine company based in Cambridge, Massachusetts, focused on transforming the drug discovery process. The company employs a novel allosteric drug-discovery platform, known as Dynamo, which integrates advanced computational techniques with experimental methods to study protein motion and interactions. This innovative approach enables the identification and development of therapies targeting complex diseases, particularly in oncology. Relay Therapeutics is advancing a pipeline of product candidates, including RLY-1971, a small molecule inhibitor targeting SHP2, RLY-4008, a selective inhibitor of FGFR2 for advanced solid tumors, and RLY-PI3K1047, aimed at mutant variants of phosphoinositide 3-kinase alpha. Founded in 2015, the company aims to deliver life-changing therapies to patients by addressing previously intractable targets in precision oncology and genetic diseases.

Zymergen

Series C in 2018
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. Founded in 2013 and headquartered in Emeryville, California, Zymergen employs a platform that integrates automation, machine learning, and genomics to enhance the efficiency of microbial strain optimization and production processes. This technology enables the company to improve existing manufacturing strains and facilitates the development of new products by engineering novel molecules from microbes. With additional offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, Zymergen aims to partner with nature to create innovative materials and products that deliver significant value across multiple sectors.

Automation Anywhere

Series A in 2018
Automation Anywhere, Inc. is a global leader in Robotic Process Automation (RPA), specializing in the development of AI-powered software solutions designed to enhance business efficiency. Founded in 2003 and headquartered in San Jose, California, the company offers a cloud-native platform that integrates RPA with artificial intelligence, machine learning, and analytics. Its flagship products include Automation Anywhere Enterprise, which automates IT and business processes; Automation Anywhere Server for streamlined business operations; and IQ Bot, a cognitive automation solution that addresses complex business tasks. Additionally, the company provides a comprehensive suite of testing tools, such as Testing Anywhere, which supports quality assurance across various platforms. Automation Anywhere also offers consulting services and collaborates strategically with Microsoft Azure. The company has expanded its presence internationally with offices in several major cities across the United States, Europe, the Middle East, and Asia.

Altaeros Energies

Venture Round in 2017
Altaeros Energies, Inc. specializes in the development and supply of airborne wind turbines designed to harness high-altitude winds for renewable energy generation. Established in 2010 and located in Somerville, Massachusetts, the company’s innovative products target various sectors, including rural and island communities, agriculture, emergency response, and military operations. By combining aerospace technology with wind energy solutions, Altaeros aims to provide abundant and low-cost renewable energy. The company has garnered support from multiple funding sources, such as the U.S. Department of Agriculture and the National Science Foundation, and has been recognized with awards like the 2011 ConocoPhillips Energy Prize.

Findability Sciences

Series A in 2017
Findability Sciences specializes in leveraging big data, cognitive computing, and artificial intelligence through its flagship product, the Findability Platform®. This award-winning platform enhances data context and features self-learning capabilities, providing tailored solutions for global corporations across various sectors, including insurance, retail, manufacturing, financial services, healthcare, and transportation. By unifying structured and unstructured data, the platform maximizes data asset value and facilitates conversational computing via chatbots and virtual agents. It generates actionable insights that enable marketing professionals to understand consumer personas and predict trends related to costs, pricing, and risks more accurately than ever before. Headquartered near Boston, MA, Findability Sciences operates in the United States, Japan, and India, and collaborates with major technology providers, including being part of the IBM Watson Partner Ecosystem. The company is also invested in a joint venture with SoftBank and a privately held predictive modeling technology firm.

Cybereason

Series D in 2017
Cybereason Inc. is a cybersecurity company that specializes in endpoint protection, offering a comprehensive platform for endpoint detection and response, next-generation antivirus, and anti-ransomware solutions. Founded in 2012 and headquartered in Boston, Massachusetts, with additional offices in London, Tel Aviv, and Tokyo, Cybereason's platform is distinguished by its custom-built in-memory graph, an automated hunting engine that identifies behavioral patterns across endpoints and reveals malicious operations. The platform includes various products designed to detect, analyze, and respond to cyber threats in real time, such as Deep Detect & Respond, Deep Prevent, Deep Investigate, and Deep Respond. Among its offerings is RansomFree, which protects against ransomware attacks. The company also provides managed monitoring services, surveillance, investigation, and training to bolster enterprise security against advanced cyber adversaries.

Boston Dynamics

Acquisition in 2017
Boston Dynamics, Inc. is an engineering company based in Waltham, Massachusetts, specializing in the design and manufacture of advanced robots and software for human simulation. Founded in 1992 as a spin-off from the Massachusetts Institute of Technology, the company has gained recognition for its innovative robots that mimic animal movement, such as Spot, a quadruped robot, and Atlas, a humanoid robot. These robots are equipped with cutting-edge mobility, dexterity, and intelligence, allowing them to perform tasks in challenging environments, including industrial plants, construction sites, and warehouses. Boston Dynamics also develops software for human simulation, which is utilized in various training applications, including law enforcement and military operations. The company collaborates with organizations globally, providing solutions to some of the most complex challenges in automation and robotics.

Zymergen

Series B in 2016
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. Founded in 2013 and headquartered in Emeryville, California, Zymergen employs a platform that integrates automation, machine learning, and genomics to enhance the efficiency of microbial strain optimization and production processes. This technology enables the company to improve existing manufacturing strains and facilitates the development of new products by engineering novel molecules from microbes. With additional offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, Zymergen aims to partner with nature to create innovative materials and products that deliver significant value across multiple sectors.

Interactions

Venture Round in 2016
Interactions LLC is a technology company that specializes in providing hosted interactive voice response (IVR) services and intelligent virtual assistant solutions. Founded in 2004 and headquartered in Franklin, Massachusetts, with additional offices in locations including Austin, Texas, and Carmel, Indiana, the company develops advanced natural language understanding technology that integrates human and machine intelligence. Its notable offerings include HumanTouch, a platform for engaging customer conversations, and Curo Speech, an application that modernizes customer care interactions through automatic speech recognition. Interactions serves a diverse range of industries, including financial services and technology, and its solutions are utilized by numerous Fortune 500 companies. The company's technology enables businesses to automate natural language communications, enhancing customer service while driving cost efficiencies and improved operational performance. With over one billion transactions handled, Interactions continues to play a pivotal role in transforming customer care through digital innovation.

Rize

Seed Round in 2016
Rize Inc. is a Woburn, Massachusetts-based company specializing in the manufacturing and marketing of full-color, multi-material 3D printers. Founded in 2012, Rize has developed hybrid 3D printing technology that combines material extrusion and material jetting. This innovation allows for the production of parts that closely resemble injection-molded components while offering an office-friendly, one-touch experience. Rize's solutions cater to a range of applications, including additive manufacturing for prototyping, service parts, and tooling. The company's focus on sustainability and inclusivity aims to facilitate scalable additive innovation, enabling businesses of all sizes to leverage advanced 3D printing technologies efficiently and cost-effectively.

Cybereason

Series C in 2015
Cybereason Inc. is a cybersecurity company that specializes in endpoint protection, offering a comprehensive platform for endpoint detection and response, next-generation antivirus, and anti-ransomware solutions. Founded in 2012 and headquartered in Boston, Massachusetts, with additional offices in London, Tel Aviv, and Tokyo, Cybereason's platform is distinguished by its custom-built in-memory graph, an automated hunting engine that identifies behavioral patterns across endpoints and reveals malicious operations. The platform includes various products designed to detect, analyze, and respond to cyber threats in real time, such as Deep Detect & Respond, Deep Prevent, Deep Investigate, and Deep Respond. Among its offerings is RansomFree, which protects against ransomware attacks. The company also provides managed monitoring services, surveillance, investigation, and training to bolster enterprise security against advanced cyber adversaries.

Glamsquad

Series B in 2015
Glamsquad, Inc., also known as GLAM Group, is a New York-based company that specializes in providing on-demand beauty services. Founded in 2013, Glamsquad offers a range of services including hair styling, makeup application, and nail care, catering to clients in major cities such as New York City, Los Angeles, Miami, Washington, D.C., Boston, and the San Francisco Bay Area. The company employs a network of trained and vetted beauty professionals who deliver personalized experiences for various occasions, including home appointments, parties, and weddings. Glamsquad leverages technology to facilitate easy booking through its app and website, ensuring clients can select services, schedule appointments, and enjoy the convenience of professional beauty care at home. In addition to services, Glamsquad has introduced its own line of hair and makeup products, designed to complement their offerings and meet client needs.

FlightCar

Series B in 2015
FlightCar, Inc. is a car rental service that operates an online platform connecting car owners with travelers in need of vehicles while at the airport. Founded in 2012 and based in San Francisco, California, FlightCar allows individuals who are parking their cars at airports to rent them out to other approved travelers, providing a cost-effective and convenient option for transportation. The company has expanded its services to multiple locations across the United States, including major cities such as Austin, Boston, Chicago, Los Angeles, and Seattle. By facilitating this peer-to-peer rental system, FlightCar aims to enhance the travel experience for both car owners and renters, promoting a collaborative community among travelers.

Altaeros Energies

Venture Round in 2014
Altaeros Energies, Inc. specializes in the development and supply of airborne wind turbines designed to harness high-altitude winds for renewable energy generation. Established in 2010 and located in Somerville, Massachusetts, the company’s innovative products target various sectors, including rural and island communities, agriculture, emergency response, and military operations. By combining aerospace technology with wind energy solutions, Altaeros aims to provide abundant and low-cost renewable energy. The company has garnered support from multiple funding sources, such as the U.S. Department of Agriculture and the National Science Foundation, and has been recognized with awards like the 2011 ConocoPhillips Energy Prize.

Glamsquad

Series A in 2014
Glamsquad, Inc., also known as GLAM Group, is a New York-based company that specializes in providing on-demand beauty services. Founded in 2013, Glamsquad offers a range of services including hair styling, makeup application, and nail care, catering to clients in major cities such as New York City, Los Angeles, Miami, Washington, D.C., Boston, and the San Francisco Bay Area. The company employs a network of trained and vetted beauty professionals who deliver personalized experiences for various occasions, including home appointments, parties, and weddings. Glamsquad leverages technology to facilitate easy booking through its app and website, ensuring clients can select services, schedule appointments, and enjoy the convenience of professional beauty care at home. In addition to services, Glamsquad has introduced its own line of hair and makeup products, designed to complement their offerings and meet client needs.

FlightCar

Series A in 2014
FlightCar, Inc. is a car rental service that operates an online platform connecting car owners with travelers in need of vehicles while at the airport. Founded in 2012 and based in San Francisco, California, FlightCar allows individuals who are parking their cars at airports to rent them out to other approved travelers, providing a cost-effective and convenient option for transportation. The company has expanded its services to multiple locations across the United States, including major cities such as Austin, Boston, Chicago, Los Angeles, and Seattle. By facilitating this peer-to-peer rental system, FlightCar aims to enhance the travel experience for both car owners and renters, promoting a collaborative community among travelers.

Interactions

Venture Round in 2013
Interactions LLC is a technology company that specializes in providing hosted interactive voice response (IVR) services and intelligent virtual assistant solutions. Founded in 2004 and headquartered in Franklin, Massachusetts, with additional offices in locations including Austin, Texas, and Carmel, Indiana, the company develops advanced natural language understanding technology that integrates human and machine intelligence. Its notable offerings include HumanTouch, a platform for engaging customer conversations, and Curo Speech, an application that modernizes customer care interactions through automatic speech recognition. Interactions serves a diverse range of industries, including financial services and technology, and its solutions are utilized by numerous Fortune 500 companies. The company's technology enables businesses to automate natural language communications, enhancing customer service while driving cost efficiencies and improved operational performance. With over one billion transactions handled, Interactions continues to play a pivotal role in transforming customer care through digital innovation.

FlightCar

Series A in 2013
FlightCar, Inc. is a car rental service that operates an online platform connecting car owners with travelers in need of vehicles while at the airport. Founded in 2012 and based in San Francisco, California, FlightCar allows individuals who are parking their cars at airports to rent them out to other approved travelers, providing a cost-effective and convenient option for transportation. The company has expanded its services to multiple locations across the United States, including major cities such as Austin, Boston, Chicago, Los Angeles, and Seattle. By facilitating this peer-to-peer rental system, FlightCar aims to enhance the travel experience for both car owners and renters, promoting a collaborative community among travelers.

Celtra

Series B in 2013
Celtra Inc. is a creative management platform that offers cloud-based, self-service software for managing the lifecycle of digital advertising. Founded in 2006 and headquartered in Boston, Massachusetts, Celtra serves advertisers, publishers, and businesses globally, with additional offices in New York, San Francisco, London, Ljubljana, and Singapore. The company's flagship product, AdCreator 4, enables agencies and brand leaders to create, distribute, and optimize data-driven display advertising campaigns across various screens, including mobile devices, tablets, and desktops. This platform facilitates large-scale and complex campaigns by streamlining ad creation, performance optimization, and consolidated reporting, ensuring that clients can easily access common metrics across all formats. Celtra operates as a subsidiary of The Unilever Group.

JNJ Mobile

Venture Round in 2010
JNJ Mobile, Inc. operates a mobile social community that facilitates connections among users through games and social interaction. Founded in 2005 and headquartered in Boston, Massachusetts, with an additional office in Herzliya, Israel, the company provides a platform that allows members to engage with one another via web-enabled mobile phones. Users can play games, chat, and meet new people, fostering a vibrant and multicultural community experience accessible across various devices, including iPhones, Android phones, iPads, and Android tablets.

MocoSpace

Venture Round in 2010
MocoSpace is the largest mobile gaming community in North America, with twenty-two million registered users. Every day, one million games are played and gamers spend over one million hours on the MocoSpace Game Platform. For a young, multicultural, on-the-go generation, MocoSpace is the mobile community of choice for playing games, making friends, having fun and staying connected. MocoSpace is free and available on any Web-enabled mobile phone in the world. Launched in 2005, MocoSpace is based in Boston, Mass., and is backed by General Catalyst and Softbank Capital. In 2010, the company launched the MocoSpace Game Platform; by the end of 2011, over 30 HTML5 games have launched on the Platform. MocoSpace has created a $2million HTML Game Developer Fund to encourage development of mobile HTML5 games. For more information, visit www.jnjmobile.com Follow MocoSpace on Twitter: http://www.twitter.com/mocospace

Panacea Pharmaceuticals

Series D in 2006
The Company has collaborated with M.D. Anderson Cancer Center in Houston, Texas; Massachusetts Institute of Technology in Cambridge, Massachusetts; and Rhode Island Hospital/Brown University in Providence, Rhode Island where teams of researchers are continuing advances on the Company's core technologies.

CyberArk Software

Series B in 2002
CyberArk Software, established in 1999, is a leading global cybersecurity company headquartered in Newton, Massachusetts. It specializes in privileged access management, a critical aspect of identity security, with over half of the Fortune 500 companies as its customers. CyberArk's core offering helps businesses protect their most valuable assets by preventing cyber threats and stopping attack escalation. With around 9,000 customers across diverse industries and a presence in multiple countries, the company has transitioned to a subscription-based revenue model.

Harmonix Corp

Venture Round in 2000
HXI was founded as Harmonix Corporation in 1992. The company was originally located in Woburn, Massachusetts and was a pioneer in the development of short-range, high data rate, wireless communication links for densely populated areas, such as Tokyo, where connection to fiber was not readily available or too expensive to be considered. The solution was a 100 Mbps, 60 GHz radio link that could easily be deployed on rooftops, behind windows, etc. Financial backing came from Omron Corporation and SoftBank, both Japanese companies, and the capability to develop and manufacture the radio link was built up around the founders. Engineers, technicians and assemblers came from companies such as Lockheed Sanders (now BAE Systems), Textron, Alpha Industries, M/A-COM and Millitech to form the core millimeter wave group that is still in place today. Radio link deployments were originally in Japan and expanded to the U.S. when regulations were established. In October 2000, Harmonix became the first company to obtain certification for a radio product under the FCC regulations for the newly established 57 - 64 GHz band. A complementary Components and Sub-systems business, servicing government contractors, subcontractors, government entities and educational institutions, was a natural extension of the radio business, as the technology already existed within the company. The HXI brand name was established around this time and was used for both businesses.

AllAdvantage

Venture Round in 2000
As of January 2001, AllAdvantage Inc. went out of business. AllAdvantage.com, Inc. operates as an Internet advertising company. It pays its users/members a portion of the advertising revenue generated by their online viewing habits. The company also allows members to receive membership benefits that include sponsor discounts and rebates for surfing the Web. In addition, it provides incentives for advertisers to build one-on-one relationships with its members. The company was founded in 1999 and is based in Hayward, California with additional offices in Atlanta, Boston, Chicago, Dallas, Detroit, Hayward, London, Los Angeles, New York, Paris, Seattle, Sydney, and Washington DC.

Talk City

Series A in 1997
Talk City is a telecommunication services company. It provides online communities and interactive services for businesses and consumers. For businesses, Talk City's services, includes designing integrated customized communities, producing online events, conducting online market research, and facilitating online meetings. The company offers consumers a combination of chat rooms, home pages, web-based clubs, online events, discussion boards, and other community tools. Talk City was founded by Bernard Bernstein and is headquartered in North Andover, Massachusetts.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.